Advertisement
CLDX vs JAZZ
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a StrongBuy and JAZZ is a Hold.
CLDX's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for CLDX turned positive on October 19, 2026. Looking at past instances where CLDX's MACD turned positive, the stock continued to rise in 36 of 46 cases over the following month. The odds of a continued upward trend are 78%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CLDX's RSI Indicator exited the oversold zone, 25 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 59 cases where CLDX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
Following a +10.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLDX advanced for three days, in 206 of 267 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
CLDX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLDX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for CLDX entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. CLDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.184) is normal, around the industry mean (2.973). P/E Ratio (-6.660) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. CLDX's P/S Ratio (10000.000) is very high in comparison to the industry average of (438.009).
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
JAZZ's Indicator enters downward trend
The Aroon Indicator for JAZZ entered a downward trend on October 22, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 130 similar instances where the Aroon Indicator formed such a pattern. In 74 of the 130 cases the stock moved lower. This puts the odds of a downward move at 57%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on JAZZ as a result. In 53 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 55%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where JAZZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where JAZZ's RSI Oscillator exited the oversold zone, 18 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 64%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where JAZZ advanced for three days, in 178 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
JAZZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 42 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 44 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. JAZZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.902) is normal, around the industry mean (2.973). P/E Ratio (14.112) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.941) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (3.407) is also within normal values, averaging (438.009).
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
CLDX | JAZZ | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 62 | 70 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 98 Overvalued | 87 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 42 | |
SMR RATING 1..100 | 98 | 44 | |
PRICE GROWTH RATING 1..100 | 64 | 56 | |
P/E GROWTH RATING 1..100 | 22 | 97 | |
SEASONALITY SCORE 1..100 | n/a | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
JAZZ's Valuation (87) in the Pharmaceuticals Other industry is in the same range as CLDX (98) in the Biotechnology industry. This means that JAZZ’s stock grew similarly to CLDX’s over the last 12 months.
JAZZ's Profit vs Risk Rating (42) in the Pharmaceuticals Other industry is somewhat better than the same rating for CLDX (100) in the Biotechnology industry. This means that JAZZ’s stock grew somewhat faster than CLDX’s over the last 12 months.
JAZZ's SMR Rating (44) in the Pharmaceuticals Other industry is somewhat better than the same rating for CLDX (98) in the Biotechnology industry. This means that JAZZ’s stock grew somewhat faster than CLDX’s over the last 12 months.
JAZZ's Price Growth Rating (56) in the Pharmaceuticals Other industry is in the same range as CLDX (64) in the Biotechnology industry. This means that JAZZ’s stock grew similarly to CLDX’s over the last 12 months.
CLDX's P/E Growth Rating (22) in the Biotechnology industry is significantly better than the same rating for JAZZ (97) in the Pharmaceuticals Other industry. This means that CLDX’s stock grew significantly faster than JAZZ’s over the last 12 months.
| CLDX | JAZZ | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 74% | 1 day ago 64% |
| Stochastic ODDS (%) | 1 day ago 76% | 1 day ago 63% |
| Momentum ODDS (%) | N/A | 1 day ago 55% |
| MACD ODDS (%) | 1 day ago 78% | N/A |
| TrendWeek ODDS (%) | 1 day ago 79% | 1 day ago 62% |
| TrendMonth ODDS (%) | 1 day ago 79% | 1 day ago 57% |
| Advances ODDS (%) | 3 days ago 77% | 18 days ago 61% |
| Declines ODDS (%) | 1 day ago 78% | 4 days ago 55% |
| BollingerBands ODDS (%) | 1 day ago 71% | 1 day ago 71% |
| Aroon ODDS (%) | 1 day ago 83% | 1 day ago 57% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CLDX’s FA Score shows that 1 FA rating(s) are green while JAZZ’s FA Score has 0 green FA rating(s).
- CLDX’s FA Score: 1 green, 4 red.
- JAZZ’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CLDX’s TA Score shows that 5 TA indicator(s) are bullish while JAZZ’s TA Score has 4 bullish TA indicator(s).
- CLDX’s TA Score: 5 bullish, 2 bearish.
- JAZZ’s TA Score: 4 bullish, 3 bearish.
Price Growth
CLDX (@Biotechnology) experienced а +0.14% price change this week, while JAZZ (@Biotechnology) price change was +0.11% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.17%. For the same industry, the average monthly price growth was -18.21%, and the average quarterly price growth was -15.24%.
Reported Earning Dates
CLDX is expected to report earnings on Nov 09, 2026.
JAZZ is expected to report earnings on Nov 02, 2026.
Industries' Descriptions
@Biotechnology (-1.17% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
JAZZ and
Correlation & Price change
A.I.dvisor indicates that over the last year, JAZZ has been loosely correlated with ZYME. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if JAZZ jumps, then ZYME could also see price increases.
| Ticker / NAME | Correlation To JAZZ | 1D Price Change % | ||
|---|---|---|---|---|
| JAZZ | 100% | +1.26% | ||
| ZYME - JAZZ | 51% Loosely correlated | +1.16% | ||
| AMLX - JAZZ | 43% Loosely correlated | -1.58% | ||
| CLDX - JAZZ | 40% Loosely correlated | -1.36% | ||
| JBIO - JAZZ | 39% Loosely correlated | -1.45% | ||
| DYN - JAZZ | 37% Loosely correlated | -1.87% | ||
More | ||||